According to Zhitong Finance App News, Saili Healthcare (603716.SH) disclosed the 2026 semi-annual report. During the reporting period, the company achieved operating income of 343 million yuan, a year-on-year decrease of 41.26%; net profit loss attributable to shareholders of listed companies of 47.52 million yuan; net profit loss attributable to shareholders of listed companies after deducting non-recurring profit and loss of 47.52 million yuan; basic earnings per share.

In recent years, affected by the normalization and expansion of collection policies, the National Health Insurance Administration has pushed the reform of DRG/DIP payment methods into a comprehensive deepening stage, and the overall profit margin of the industry has been significantly compressed. The company faced multiple challenges such as expanding procurement, controlling medical insurance costs, lengthening hospital repayment cycles, and clearing low-margin businesses. At the same time, in order to focus on core business development, the company further optimizes the company's business structure. Industry policies are linked to the company's transformation, causing the company's operating income to drop by a certain margin.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.